Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy Reply

ISSN
1879-0852
0959-8049
Date Issued
2016
Author(s)
Pompe, R. S.
Mynarek, Martin
von Hoff, Katja
Rutkowski, Stefan
DOI
10.1016/j.ejca.2015.11.011